1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Pérez-Molina JA, Díaz-Menéndez M, Gallego JI, Norman F, Monge-Maillo B, Ayala AP, López-Vélez R.

    Evaluation of nitazoxanide for the treatment of disseminated cystic echinococcosis: report of five cases and literature review.

    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE . 84(2): 351-356. Nº de citas: 27

    [doi:10.4269/ajtmh.2011.10-0513]

  • Ruiz-Camps I, Len O, MARTÍN DÁVILA, PILAR.

    Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients

    ANTIVIRAL THERAPY . 16(7): 951-957. Nº de citas: 15

    [doi:10.3851/IMP1858]

  • Yebra G, de Mulder M, Martín L, Pérez-Cachafeiro S, Rodríguez C, Labarga P, García F, Tural C, Jaén A, Navarro G, Holguín A.

    Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naïve HIV-infected patients (CoRIS).

    ANTIVIRAL RESEARCH . 89(1): 19-25. Nº de citas: 19

    [doi:10.1016/j.antiviral.2010.10.008]

  • Pérez-Molina JA, Suárez-Lozano I, Del Arco A, Teira R, Bachiller P, Pedrol E, Martínez-Alfaro E, Domingo P, Mariño A, Ribera E, Antela A, de Otero J, Navarro V, González-García J.

    Late Initiation of HAART Among HIV-Infected Patients in Spain Is Frequent and Related to a Higher Rate of Virological Failure but not to Immigrant Status

    HIV CLINICAL TRIALS . 12(1): 1-8. Nº de citas: 10

    [doi:10.1310/hct1201-1]

  • Pérez-Ayala A, Pérez-Molina JA, Norman F, Monge-Maillo B, Faro MV, López-Vélez R.

    Gastro-intestinal Chagas disease in migrants to Spain: prevalence and methods for early diagnosis.

    ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY . 105(1): 25-29. Nº de citas: 27

    [doi:10.1179/136485910X12851868780423]

  • Tural C, Solà R, Alvarez NP, Moltó J, Sánchez M, Zamora AM, Ornelas A, Laguno M, González J, von Wichmann MÁ, Téllez MJ, Paredes R, Clotet B.

    Effect of an induction period of pegylated interferon-a2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study.

    ANTIVIRAL THERAPY . 16(6): 833-841. Nº de citas: 1

    [doi:10.3851/IMP1837]

  • Parra J, Portilla J, Pulido F, Sánchez-de la Rosa R, Alonso-Villaverde C, Berenguer J, Blanco JL, Domingo P, Dronda F, Galera C, Gutiérrez F, Kindelán JM, Knobel H, Leal M, López-Aldeguer J, Mariño A, Miralles C, Moltó J, Ortega E, Oteo JA.

    Clinical utility of maraviroc.

    CLINICAL DRUG INVESTIGATION . 31(8): 527-542. Nº de citas: 25

    [doi:10.2165/11590700-000000000-00000]

  • Moreno S, González J, Lekander I, Martí B, Oyagüez I, Sánchez-de la Rosa R, Casado MA.

    Cost-effectiveness of optimized background therapy plus maraviroc for previously treated patients with R5 HIV-1 infection from the perspective of the Spanish health care system.

    Clinical therapeutics . 32(13): 2232-2245. Nº de citas: 3

    [doi:10.1016/S0149-2918(10)80026-8]

  • García-Leoni ME, Moreno S, García-Garrote F, Cercenado E.

    Ventilator-associated pneumonia in long-term ventilator-assisted individuals

    Spinal Cord . 48(12): 876-880. Nº de citas: 10

    [doi:10.1038/sc.2010.43]

  • Field V, Gautret P, Schlagenhauf P, Burchard GD, Caumes E, Jensenius M, Castelli F, Gkrania-Klotsas E, Weld L, Lopez-Velez R, de Vries P, von Sonnenburg F, Loutan L, Parola P.

    Travel and migration associated infectious diseases morbidity in Europe, 2008.

    BMC INFECTIOUS DISEASES . 10: 330-330. Nº de citas: 104

    [doi:10.1186/1471-2334-10-330]

  • Reekie J, Kosa C, Engsig F, Monforte Ad, Wiercinska-Drapalo A, Domingo P, Antunes F, Clumeck N, Kirk O, Lundgren JD, Mocroft A.

    Relationship Between Current Level of Immunodeficiency and Non-Acquired Immunodeficiency Syndrome-Defining Malignancies

    CANCER . 116(22): 5306-5315. Nº de citas: 106

    [doi:10.1002/cncr.25311]

  • Friis-Møller N, Thiébaut R, Reiss P, Weber R, Monforte AD, De Wit S, El-Sadr W, Fontas E, Worm S, Kirk O, Phillips A, Sabin CA, Lundgren JD, Law MG, DAD study group.

    Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study

    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION . 17(5): 491-501. Nº de citas: 262

    [doi:10.1097/HJR.0b013e328336a150]

  • Mocroft A, Reiss P, Gasiorowski J, Ledergerber B, Kowalska J, Chiesi A, Gatell J, Rakhmanova A, Johnson M, Kirk O, Lundgren J.

    Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 55(2): 262-270. Nº de citas: 194

    [doi:10.1097/QAI.0b013e3181e9be6b]

  • Fortun J, Martin-Davila P, Pascual J, Cervera C, Moreno A, Gavalda J, Aguado JM, Pereira P, Gurguí M, Carratala J, Fogueda M, Montejo M, Blasco F, Bou G, Torre-Cisneros J.

    Immunosuppressive therapy and infection after kidney transplantation

    TRANSPLANT INFECTIOUS DISEASE . 12(5): 397-405. Nº de citas: 44

    [doi:10.1111/j.1399-3062.2010.00526.x]

  • Pérez Molina JA, Rillo MM, Suárez-Lozano I, Casado Osorio JL, Cobo RT, González PR, Clotet EP, Jerez AH, Pedrol PD, Royuela A, Díaz EB, Esteban H, González-García J.

    Do HIV-Infected Immigrants Initiating HAART have Poorer Treatment-Related Outcomes than Autochthonous Patients in Spain? Results of the GESIDA 5808 Study

    CURRENT HIV RESEARCH . 8(7): 521-530. Nº de citas: 18

  • Blanco JR, Caro AM, Pérez-Cachafeiro S, Gutiérrez F, Iribarren JA, González-García J, Ferrando-Martínez S, Navarro G, Moreno S.

    HIV Infection and Aging

    AIDS REVIEWS . 12(4): 218-230. Nº de citas: 42

  • Diaz A, Diez M, Bleda MJ, Aldamiz M, Camafort M, Camino X, Cepeda C, Costa A, Ferrero O, Geijo P, Iribarren JA, Moreno S, Moreno ME, Labarga P, Pinilla J, Portu J, Pulido F, Rosa C, Santamaría JM, Telenti M, Trapiella L, Trastoy M, Viciana P.

    Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain

    BMC INFECTIOUS DISEASES . 10: 267-267. Nº de citas: 14

    [doi:10.1186/1471-2334-10-267]

  • Zamarrón Fuertes P, Pérez-Ayala A, Pérez Molina JA, Norman FF, Monge-Maíllo B, Navarro M, López-Vélez R.

    Clinical and epidemiological characteristics of imported infectious diseases in Spanish travelers.

    JOURNAL OF TRAVEL MEDICINE . 17(5): 303-309. Nº de citas: 33

    [doi:10.1111/j.1708-8305.2010.00433.x]